Comprehensive Assessment of Neurodegeneration and Dementia
Conditions
Dementia · Mild Cognitive Impairment (MCI) · Subjective Cognitive Impairment · Parkinson's Disease (PD) · Lewy Body Disease(LBD) · Mixed Dementia · Frontotemporal Dementia (FTD) · Alzheimer Disease (AD) · Cognitively Unimpaired · Subjective Cognitive Decline (SCD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Calgary, Calgary, Alberta, Canada
University of Alberta Hospital, Edmonton, Alberta, Canada
Djavad Mowafaghian Centre for Brain Health, Vancouver, British Columbia, Canada
Island Health, Victoria, British Columbia, Canada
Veteran's Memorial Building, Halifax, Nova Scotia, Canada
Hamilton General Hospital, Hamilton, Ontario, Canada
St. Joseph's Health Care London, London, Ontario, Canada
Gait and Brain Lab, London, Ontario, Canada
Bruyère Research Institute, Ottawa, Ontario, Canada
Kawartha Centre, Peterborough, Ontario, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
University Health Network Memory Clinic, Toronto, Ontario, Canada
Baycrest Clinical Unit, Toronto, Ontario, Canada
University of Waterloo, Waterloo, Ontario, Canada
Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
Jewish General Hospital/McGill Memory Clinic, Montreal, Quebec, Canada
Clinique de cognition Institut universitaire de gériatrie de Montréal, Montreal, Quebec, Canada
Contact: Study coordinator (Marie-Jeanne Kergoat, MD) · marie-jeanne.kergoat@umontreal.ca · 514 340-3540Hôpital Enfant-Jésus, Québec, Quebec, Canada
Centre de recherche sur le vieillissement CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada
Study leads
Michael Borrie, MD
Study Director
Western University
Natalie Philips, PhD
Study Director
Concordia University, Montreal
Jaspreet Bhangu, MB
Study Director
Western University